The global coronavirus immunoassay market continues to witness steady growth, reaching USD 3.7 billion in 2021 and is projected to exceed USD 6.9 billion by 2032, expanding at a CAGR of 5.5% during ...

Research also showed that the test has a very low false positive rate. VolitionRx Limited announced that its Nu.Q cancer immunoassay test was able to detect at least 21 different cancers in a recent ...

It’s no secret that Tropical Storm Helene devastated growers in Western North Carolina. And this year’s growing season is ...

Pharmaceutical company sponsorship of diagnostic testing remains an area with a gaping divide between the views of regulators and industry, ...

VolitionRx (VNRX) announces the results of a study which shows that an automated Nu.Q Cancer immunoassay test in development detected a range ...

For the first time, scientists have identified promising drug candidates that bind irreversibly with a notoriously ...

Bio-Rad’s assays use real-time polymerase chain reaction technology to amplify and detect specific DNA sequences of target ...

During a Community Case Forum event in partnership with the Texas Society of Clinical Oncology, Natalie Vokes, MD, discussed ...

NEW YORK – Cancer diagnostics firm AccuStem Sciences announced on Tuesday that it has acquired the license for the proprietary MicroRNA Signature Classifier (MSC) test for lung cancer screening from ...

A team that includes a RIKEN researcher has refined a lab test for measuring protein aggregate levels in samples from patients with certain neurodegenerative diseases. This has the potential to ...

A home urine test demonstrated high sensitivity for detection of aggressive prostate cancer, according to study findings.The ...

The study demonstrates that PAC-MANN-1 outperforms the widely used CA 19-9 biomarker, offering greater accuracy in detecting all stages of PDAC. The assay is particularly promising for identifying ...